JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES, cilt.6, sa.1, ss.296-304, 2022 (ESCI)
Objevtive: Prostate cancer is the the second common cancer in men in Turkey. We aimed to share our single center experience on the characteristics of patients with metastatic castration sensitive prostate cancer (mCSPC) and the factors affecting survival.